Literature DB >> 15276478

Atrial natriuretic peptide modulates the hyperpolarization-activated current (If) in human atrial myocytes.

Giuseppe Lonardo1, Elisabetta Cerbai, Simona Casini, Gabriele Giunti, Massimo Bonacchi, Francesco Battaglia, Brenno Fiorani, Pier Luigi Stefano, Guido Sani, Alessandro Mugelli.   

Abstract

OBJECTIVES: The relationship between atrial stretching and changes in cell excitability is well documented. Once stretched, human atrial myocytes (HuAM) release atrial natriuretic peptide (hANP). Receptors for hANP (NPR) are coupled to a guanylyl cyclase (GC) activity, and are present on HuAM, but the electrophysiological effects of hANP are largely unknown. We investigated the effect of hANP on If, the hyperpolarization-activated current present in HuAM, and the underlying intracellular pathway.
METHODS: HuAM were isolated from atrial appendages and utilized for patch-clamp recording.
RESULTS: hANP caused a significant and concentration dependent shift of the midpoint activation potential (DeltaVh) toward less negative potentials of 6.9 +/- 1.0 mV at 0.1 nM; 13.0 +/- 2.6 mV at 1 nM and 15.3 +/- 2.2 mV at 10 nM (p < 0.001 for all); a parallel increase of If rate of activation occurred. The effect of hANP was completely blocked by isatin, a potent antagonist of NPR (p < 0.01 vs. hANP). In the presence of the inhibitors of guanylyl cyclase (ODQ and LY83583), hANP caused a significantly smaller DeltaVh (p < 0.01 vs. hANP for both). 8Br-cGMP mimicked the effect of hANP, both in the presence and absence of KT5823, a selective inhibitor of Protein kinase G. Pretreatment with pertussis toxin (PTX) did not change the effect of hANP, thus excluding a major role for the coupling of NPR with the Gi-Proteins system. Pretreating cells with cyclopentyladenosine (CPA), an A1-adenosine receptor agonist, completely blocked hANP effect. Adding hANP to maximal serotonin concentration produced an additive response.
CONCLUSIONS: Our data demonstrate for the first time that ANP is able to increase If, likely through a modulation of intracellular cGMP and cAMP levels. This effect could have implications in the relationship between stretch and arrhythmogenesis in the human atrium. Copryright 2004 European Society of Cardiology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276478     DOI: 10.1016/j.cardiores.2004.03.004

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  15 in total

Review 1.  Monogenic atrial fibrillation as pathophysiological paradigms.

Authors:  Saagar Mahida; Steven A Lubitz; Michiel Rienstra; David J Milan; Patrick T Ellinor
Journal:  Cardiovasc Res       Date:  2010-11-30       Impact factor: 10.787

2.  Electrophysiologic and molecular mechanisms of a frameshift NPPA mutation linked with familial atrial fibrillation.

Authors:  Ambili Menon; Liang Hong; Eleonora Savio-Galimberti; Arvind Sridhar; Seock-Won Youn; Meihong Zhang; Kaylen Kor; Marcia Blair; Sabina Kupershmidt; Dawood Darbar
Journal:  J Mol Cell Cardiol       Date:  2019-05-08       Impact factor: 5.000

3.  Association of Longitudinal Changes in Cardiac Biomarkers With Atrial and Ventricular Arrhythmias (from the Atherosclerosis Risk in Communities [ARIC] Study).

Authors:  Parveen K Garg; Faye L Norby; Wendy Wang; Darshan Krishnappa; Elsayed Z Soliman; Pamela L Lutsey; Elizabeth Selvin; Christie M Ballantyne; Alvaro Alonso; Lin Y Chen
Journal:  Am J Cardiol       Date:  2021-08-28       Impact factor: 2.778

4.  Molecular and functional evidence of HCN4 and caveolin-3 interaction during cardiomyocyte differentiation from human embryonic stem cells.

Authors:  Alexis Bosman; Laura Sartiani; Valentina Spinelli; Martina Del Lungo; Francesca Stillitano; Daniele Nosi; Alessandro Mugelli; Elisabetta Cerbai; Marisa Jaconi
Journal:  Stem Cells Dev       Date:  2013-02-27       Impact factor: 3.272

5.  N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study.

Authors:  Kristen K Patton; Patrick T Ellinor; Susan R Heckbert; Robert H Christenson; Christopher DeFilippi; John S Gottdiener; Richard A Kronmal
Journal:  Circulation       Date:  2009-10-19       Impact factor: 29.690

6.  Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation.

Authors:  Denice M Hodgson-Zingman; Margaret L Karst; Leonid V Zingman; Denise M Heublein; Dawood Darbar; Kathleen J Herron; Jeffrey D Ballew; Mariza de Andrade; John C Burnett; Timothy M Olson
Journal:  N Engl J Med       Date:  2008-07-10       Impact factor: 91.245

7.  Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillation.

Authors:  Robert L Abraham; Tao Yang; Marcia Blair; Dan M Roden; Dawood Darbar
Journal:  J Mol Cell Cardiol       Date:  2009-07-30       Impact factor: 5.000

Review 8.  Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injury.

Authors:  Punate Weerateerangkul; Siriporn Chattipakorn; Nipon Chattipakorn
Journal:  Med Sci Monit       Date:  2011-02

9.  B-type natriuretic peptide-induced delayed modulation of TRPV1 and P2X3 receptors of mouse trigeminal sensory neurons.

Authors:  Sandra Vilotti; Anna Marchenkova; Niels Ntamati; Andrea Nistri
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

10.  Biological targets for isatin and its analogues: Implications for therapy.

Authors:  Alexei Medvedev; Olga Buneeva; Vivette Glover
Journal:  Biologics       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.